ClinicalTrials.Veeva

Menu

Corneal Endothelial Cell Injury Induced by Mitomycin-C

A

Al-Azhar University

Status

Enrolling

Conditions

Myopia

Treatments

Procedure: Alcohol-Assisted PRK/MMC
Procedure: Transepithelial PRK/MMC

Study type

Interventional

Funder types

Other

Identifiers

NCT05548478
Mitomycin-C

Details and patient eligibility

About

our study will investigate the effecacy of Mitomycin-C in TransEpi single step photorefractive keratectomy (PRK) and alcohol assisted PRK

Enrollment

60 estimated patients

Sex

All

Ages

17 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 18 years.
  • Primary myopia or compound myopic astigmatism.
  • Preoperative manifest refraction spherical equivalent (MRSE) within the range of -1.0 to 8 D
  • Stable refractive error for at least 12 months before the surgery.
  • Contact lens discontinuation for at least 3 weeks.
  • Estimated corneal stromal bed thickness of more than 300mm at the thinnest point

Exclusion criteria

  • Unwilling to participate in the study.
  • Previous ocular surgery
  • Any diagnosed ocular disease
  • History of ocular trauma

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

TransEpi single step PRK
Active Comparator group
Treatment:
Procedure: Transepithelial PRK/MMC
alcohol assisted PRK
Active Comparator group
Treatment:
Procedure: Alcohol-Assisted PRK/MMC

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems